Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

STAXAR 50 MG PELICULAS BUCODISPERSABLES EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/STAXAR 50 MG PELICULAS BUCODISPERSABLES EFG

Approved

STANDARD

STAXAR 50 MG PELICULAS BUCODISPERSABLES EFG

Farmitalia S.R.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 12, 2022
Approval ID: f2d78d1fe0b87408
Company: Farmitalia S.R.L.
Type: Standard

Approval Details

Approval Id: f2d78d1fe0b87408
Drug Cima Aemps Name: STAXAR 50 MG PELICULAS BUCODISPERSABLES EFG
Register Number: 86823
Holder Company Name: Farmitalia S.R.L.
Marketing Company Name: Farmitalia S.R.L.
Authorization Date: 2022-04-12
Dosage Form: PELICULA BUCODISPERSABLE
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Farmitalia S.R.L.

Active Ingredients

SILDENAFILO CITRATO

70,240 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 12, 2022

Approval ID

f2d78d1fe0b87408

Type

Standard

Back to CIMA-AEMPS Approvals